• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有氨基酸模拟片段的分子钳:野生型和突变型HIV-1蛋白酶二聚化的新型抑制剂

Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.

作者信息

Bannwarth Ludovic, Kessler Albane, Pèthe Stéphanie, Collinet Bruno, Merabet Naïma, Boggetto Nicole, Sicsic Sames, Reboud-Ravaux Michèle, Ongeri Sandrine

机构信息

Université de Paris-Sud XI, IFR 141, Biocis, UMR-CNRS 8076, Faculté de Pharmacie, 5 Rue J. B. Clément, F-92296 Châtenay-Malabry Cedex, France.

出版信息

J Med Chem. 2006 Jul 27;49(15):4657-64. doi: 10.1021/jm060576k.

DOI:10.1021/jm060576k
PMID:16854071
Abstract

We have designed, synthesized, and evaluated the inhibitory activity and metabolic stability of new peptidomimetic molecular tongs based on a naphthalene scaffold for inhibiting HIV-1 protease dimerization. Peptidomimetic motifs were inserted into one peptidic strand to make it resistant to proteolysis. The peptidic character of the molecular tongs can be decreased without changing the way they inhibit dimerization. Mutated HIV-1 proteases are also vulnerable to dimerization inhibitors, and the multimutated protease ANAM-11 is twice as sensitive to the inhibitor compared to wild-type protease. Thus, the metabolic stability of antidimeric molecular tongs can be increased without compromising their ability to inhibit wild-type and mutated HIV-1 proteases in vitro.

摘要

我们设计、合成并评估了基于萘支架的新型拟肽分子钳的抑制活性和代谢稳定性,以抑制HIV-1蛋白酶二聚化。将拟肽基序插入一条肽链中,使其具有抗蛋白水解能力。在不改变分子钳抑制二聚化方式的情况下,可以降低其肽性。突变的HIV-1蛋白酶也易受二聚化抑制剂的影响,与野生型蛋白酶相比,多突变蛋白酶ANAM-11对该抑制剂的敏感性是其两倍。因此,可以提高抗二聚体分子钳的代谢稳定性,同时不影响其在体外抑制野生型和突变型HIV-1蛋白酶的能力。

相似文献

1
Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.含有氨基酸模拟片段的分子钳:野生型和突变型HIV-1蛋白酶二聚化的新型抑制剂
J Med Chem. 2006 Jul 27;49(15):4657-64. doi: 10.1021/jm060576k.
2
Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerization.一种针对野生型和突变型 HIV-1 蛋白酶二聚化的首个非肽类分子钳抑制剂。
ChemMedChem. 2010 Nov 8;5(11):1899-906. doi: 10.1002/cmdc.201000308.
3
Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.基于碳酰肼的分子钳抑制野生型和突变型 HIV-1 蛋白酶二聚化。
J Med Chem. 2012 Aug 9;55(15):6762-75. doi: 10.1021/jm300181j. Epub 2012 Jul 31.
4
Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization.HIV-1蛋白酶二聚化新型抑制剂——构象受限钳形物的设计、合成与评估
J Med Chem. 1999 Mar 25;42(6):957-62. doi: 10.1021/jm9803976.
5
Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.烷基三肽破坏二聚体和隔离单体是抑制野生型和多药耐药突变型HIV-1蛋白酶的成功策略。
Biochemistry. 2009 Jan 20;48(2):379-87. doi: 10.1021/bi801422u.
6
New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer.旨在解离HIV-1蛋白酶二聚体的新型受限“分子钳”。
J Med Chem. 2004 Dec 2;47(25):6392-400. doi: 10.1021/jm040833q.
7
Development of low molecular weight HIV-1 protease dimerization inhibitors.低分子量HIV-1蛋白酶二聚化抑制剂的研发
J Med Chem. 2005 Mar 24;48(6):2239-42. doi: 10.1021/jm049581j.
8
An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.一种乙二胺抑制剂与野生型和突变型HIV-1蛋白酶都紧密结合。结构与能量研究。
J Med Chem. 2003 Apr 24;46(9):1636-44. doi: 10.1021/jm021079g.
9
Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.野生型和突变型HIV蛋白酶的小分子二聚化抑制剂:一种聚焦文库方法
J Am Chem Soc. 2004 Aug 18;126(32):9886-7. doi: 10.1021/ja048139n.
10
Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.非天然D-氨基酸衍生物与去甲二氢愈创木酸-二甲基硫代脯氨酸支架在HIV蛋白酶抑制剂中的组合对突变型HIV具有高效性。
J Med Chem. 2008 May 22;51(10):2992-3004. doi: 10.1021/jm701555p. Epub 2008 Apr 22.

引用本文的文献

1
New insights into protein-protein interaction modulators in drug discovery and therapeutic advance.药物发现与治疗进展中蛋白质-蛋白质相互作用调节剂的新见解。
Signal Transduct Target Ther. 2024 Dec 6;9(1):341. doi: 10.1038/s41392-024-02036-3.
2
Development of peptide inhibitors of HIV transmission.HIV传播肽抑制剂的研发。
Bioact Mater. 2016 Sep 16;1(2):109-121. doi: 10.1016/j.bioactmat.2016.09.004. eCollection 2016 Dec.
3
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.用于治疗艾滋病毒/艾滋病的HIV-1蛋白酶抑制剂开发的最新进展
J Med Chem. 2016 Jun 9;59(11):5172-208. doi: 10.1021/acs.jmedchem.5b01697. Epub 2016 Jan 22.
4
Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function.HIV-1蛋白酶β-发夹瓣的合成结构模拟物可抑制酶的功能。
Bioorg Med Chem. 2015 Nov 1;23(21):7095-109. doi: 10.1016/j.bmc.2015.09.002. Epub 2015 Sep 7.
5
Current and Novel Inhibitors of HIV Protease.当前和新型 HIV 蛋白酶抑制剂。
Viruses. 2009 Dec;1(3):1209-39. doi: 10.3390/v1031209. Epub 2009 Dec 11.
6
Targeting human immunodeficiency virus type 1 assembly, maturation and budding.靶向1型人类免疫缺陷病毒的组装、成熟和出芽。
Drug Target Insights. 2007;2:159-82. Epub 2007 Jul 20.
7
The energy landscape of a selective tumor-homing pentapeptide.一种选择性肿瘤归巢五肽的能量景观
J Phys Chem B. 2008 Jul 24;112(29):8692-700. doi: 10.1021/jp711477k. Epub 2008 Jun 28.
8
Atomistic simulations of the HIV-1 protease folding inhibition.HIV-1蛋白酶折叠抑制的原子模拟
Biophys J. 2008 Jul;95(2):550-62. doi: 10.1529/biophysj.107.127621. Epub 2008 Mar 28.
9
HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.HIV-1 蛋白酶和逆转录酶控制其核衣壳伴侣的结构。
PLoS One. 2007 Aug 22;2(7):e669. doi: 10.1371/journal.pone.0000669.